AstraZeneca’s Monoclonal Antibody Works Against COVID-19 Variant Omicron: Studies
New studies show that AstraZeneca’s monoclonal antibody drug is effective against the COVID-19 variant Omicron, according to a new report.
“The company’s EVUSHELD retains neutralization activity against omicron, according to ‘live’…
Read More...
Read More...